Home/Stocks/Consumer Cyclicals

Dunelm Group PLC

DNLM.L·Consumer Cyclicals·Market Cap £1.6b
Rank #101 of 280
Quantitative Model · 280 Stocks Analysed
£8.00
-27.27% YTD
52W: £7.07 - £11.42

Factor Analysis Summary

Editorial assessment generated from Dunelm Group PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Dunelm Group PLC (DNLM.L) currently holds an overall rank of #101 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include asset efficiency, where it demonstrates highly efficient capital deployment, converting assets into revenue and returns effectively, and valuation (P/E 10.9, dividend yield 5.5%), where it demonstrates reasonable valuation with several price-based metrics ranking favourably.

Areas requiring attention include technical (RSI 56.3), where bearish technical positioning with price trading below key trend indicators, as well as liquidity, where thin trading volumes could increase transaction costs and slippage.

Within the Consumer Cyclicals sector, Dunelm Group PLC sits at composite rank #101, trailing the Consumer Cyclicals peer average (rank 44). It ranks behind all 6 tracked Consumer Cyclicals peers in our model.

The composite profile is weighed down by 4 below-average factor scores, with technical (rank 259/280) representing the most significant drag on its #101 overall standing.

Strongest Factors

  • Asset Efficiency — Rank 8/280 (top quartile)
  • Valuation — Rank 106/280 (above average)
  • Solvency — Rank 117/280 (middle of the pack)

Weakest Factors

  • Technical — Rank 259/280 (below average)
  • Liquidity — Rank 209/280 (below average)

Score Analysis

Dunelm Group PLC is ranked #101 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

156/280
Average Score
Liquidity
Weak209/280
Valuation
Good106/280
Profitability
Weak187/280
Solvency
Fair117/280
Asset Efficiency
Excellent8/280
Mkt Trading
Weak207/280
Technical
Weak259/280

1. Liquidity

Score: 209/280

How liquid is DNLM and can it meet its short-term obligations?

1/6
liquidity criteria met
✗
Quick Ratio0.25x
Range: 0.7 - 1.2Rank 147/280
✗
Current Ratio1.02x
Range: 1.2 - 1.8Rank 163/280
✓
TTM Operating Cash Flow0.91x
Range: 0.8 - 1.2Rank 56/280
–
Liquidity Coverage RatioN/A
Range: N/A
✗
Intangible Asset Ratio0.02x
Range: 3 - 15Rank 124/280
✗
Cash-to-Debt Ratio0.06x
Range: 0.3 - 0.8Rank 218/280

Key Liquidity Metrics

Quick Ratio
0.25x
Sector: 0.7 - 1.2
Current Ratio
1.02x
Sector: 1.2 - 1.8

Overall Liquidity Rank

Rank within universe#209/280
Best (1)Worst (280)

2. Valuation

Score: 106/280

Is DNLM undervalued compared to its peers and fair value metrics?

0/7
valuation criteria met
✗
FY27e P/E9.9x
Range: 12x - 30xRank 60/280
✗
FY26e P/E10.5x
Range: 12x - 30xRank 50/280
✗
FY27e Net Div Yld (%)6.50%
Range: 1.0 - 4.0Rank 37/280
✗
Div Payout Ratio90.71%
Range: 25 - 50Rank 25/280
✗
Current EV/EBITDA6.5x
Range: 7.0x - 11.0xRank 91/280
✗
Current P/TBV12.56x
Range: 1.5x - 4.5xRank 208/280
✗
Current P/B11.03x
Range: 1.5x - 4.5xRank 263/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
10.9x
FY26e P/E
Forward estimate
10.5x
FY27e P/E
Forward estimate
9.9x
Current P/B
Price-to-Book
11.03x
Current P/TBV
Tangible Book Value
12.56x
Current EV/EBITDA
Enterprise Value
6.5x
FY26e EV/EBITDA
Forward estimate
5.8x
FY27e EV/EBITDA
Forward estimate
5.8x

Dividend

DNLM pays a dividend yield of 5.54%.

Current Yield
5.54%
FY27e Net Div Yield
6.50%
FY26e Gross DPS
0.593
FY27e Gross DPS
0.520

Dividend Per Share Forecast

3. Profitability

Score: 187/280

How profitable is DNLM relative to its peers?

0/7
profitability criteria met
✗
TTM Profit Margin8.5%
Range: 3 - 8Rank 164/280
✗
T12 FCF Margin1.1%
Range: 3 - 10Rank 66/280
✗
FY27e RoE82.5%
Range: 5 - 12Rank 9/280
✗
FY26 EPS Growth-2.8%
Range: 0 - 5Rank 184/280
✗
FY27e EPS Growth2.6%
Range: 5 - 12Rank 191/280
–
NIMN/A
Range: N/A
–
Expense RatioN/A
Range: 85 - 92
TTM Profit Margin
8.5%
Current RoCE
116.3%
FY27e RoE
82.5%
T12 FCF Margin
1.1%

EPS Growth

4. Solvency

Score: 117/280

How strong is DNLM's balance sheet and financial position?

0/6
solvency criteria met
✗
Debt/Eqt2.59x
Range: 0.5x - 1.2xRank 244/280
–
Interest Coverage RatioRank 98
Range: 3x - 8xRank 98/280
✗
Net Leverage Ratio0.50x
Range: 1.5x - 3.5xRank 54/280
–
Altman Z-Score (Manufacturing)5.45
Range: <1.10 - >2.60Rank 117/280
–
Z-Score (Non Manufacturing)Rank 81
Range: <1.10 - >2.60Rank 81/280
–
CapAdeq Ratio Tier1N/A
Range: N/A

Key Solvency Metrics

Debt/Eqt
2.59x
Net Leverage Ratio
0.50x
Interest Coverage
Rank 98
T12 FCF Margin
1.1%

Altman Z-Score

5.45
Safe Zone
01.812.995+

5. Asset Efficiency

Score: 8/280

How efficiently does DNLM deploy its assets and intellectual capital?

1/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: N/A
✓
TTM Asset Turnover Ratio2.44x
Range: 1.0x - 2.5xRank 5/280
✗
TTM CAPEX/Sales2.3%
Range: 3 - 8Rank 147/280
✗
Working Capital Turnover226.77x
Range: 5x - 12xRank 2/280
–
R&D/Sales FY27eN/A
Range: 0.5 - 3.0

Overall Asset Efficiency Rank

Rank within sector peers#8/280
Best (1)Worst (280)

6. Market Trading

Score: 207/280

How liquid and actively traded is DNLM?

2/2
market trading criteria met
✓
Intraday Sentiment (%)44.0%
Range: 30 - 70Rank 145/280
–
10D-Avg v/s 3M-Avg Vol77%
Range: N/ARank 50/280
✓
Avg Directional Index 30D18.5
Range: 012 - 45Rank 158/280
–
Parabolic SAR770.50
Range: N/ARank 113/280
–
Stock Rating RankRank 100
Range: N/ARank 100/280
Market Cap
£1,611,961,734
Enterprise Value
£1,973,461,734

Trading Volume

7. Technical

Score: 259/280

What do the technical indicators say about DNLM?

0/5
technical criteria met
–
CMP v/s 52-WH-30.0%
£11.42£7.07
-30.0%CMP: £8.00
Range: N/ARank 251/280
–
CMP v/s 52-WL13.1%
£11.42£7.07
+13.1%CMP: £8.00
Range: N/ARank 69/280
–
RSI 14D56.3
056.3 - Bullish100
Range: N/ARank 50/280
–
MA50 - MA200Bearish
£8.29-0.19£8.49
Range: N/ARank 232/280
–
MACD Rank4.43
Death Cross
MACD: 4.43
Range: N/ARank 100/280

RSI (14 Day)

56.3
Bullish
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£8.29
200 SMA£8.49
SignalDeath Cross (Bearish)
MACD4.43

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

Peer Comparison

How does DNLM compare to other Consumer Cyclicals stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
DNLM#101209106187117207259
GAW.L#109267933618240
NXT.L#224026194105233
FOUR.L#31135202184248212
GFTU_u.L#564914521812515311
MOONM.L#70144178158161135116
CPG.L#72156203150129266215
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for Dunelm Group PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.